2001 - Royal Netherlands Academy of Arts and Sciences
The scientist’s investigation covers issues in Internal medicine, Myocardial infarction, Cardiology, Surgery and Coronary artery disease. His study in Angioplasty, Angina, Troponin T, Troponin and Infarction are all subfields of Internal medicine. Myocardial infarction is frequently linked to Tissue plasminogen activator in his study.
In most of his Cardiology studies, his work intersects topics such as Survival rate. His Surgery research incorporates themes from Hazard ratio and Confidence interval. He has researched Coronary artery disease in several fields, including Epidemiology and Heart failure.
Maarten L. Simoons spends much of his time researching Internal medicine, Cardiology, Myocardial infarction, Surgery and Coronary artery disease. Heart failure, Unstable angina, Acute coronary syndrome, Angina and Electrocardiography are among the areas of Internal medicine where the researcher is concentrating his efforts. His study on Angioplasty, ST segment and Ejection fraction is often connected to In patient as part of broader study in Cardiology.
His work in Infarction, Thrombolysis, Streptokinase, Percutaneous coronary intervention and Eptifibatide is related to Myocardial infarction. Maarten L. Simoons frequently studies issues relating to Clinical trial and Surgery. His Coronary artery disease research focuses on subjects like Perindopril, which are linked to ACE inhibitor.
His main research concerns Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Heart failure. His Surgery research extends to the thematically linked field of Internal medicine. His Cardiology research is multidisciplinary, incorporating perspectives in Randomized controlled trial and Blood pressure.
His research on Myocardial infarction focuses in particular on Percutaneous coronary intervention. His research in Percutaneous coronary intervention intersects with topics in Conventional PCI and Left bundle branch block. His Heart failure study integrates concerns from other disciplines, such as Stroke, Revascularization, Heart disease, Microcirculation and Angina.
Maarten L. Simoons focuses on Internal medicine, Cardiology, Myocardial infarction, Coronary artery disease and Heart failure. Maarten L. Simoons performs multidisciplinary study on Internal medicine and In patient in his works. His research integrates issues of Mean arterial pressure and Hazard ratio in his study of Cardiology.
The various areas that Maarten L. Simoons examines in his Myocardial infarction study include Mortality rate, Medical emergency and Intensive care medicine. Maarten L. Simoons combines subjects such as Placebo, Perindopril and Unstable angina with his study of Coronary artery disease. The concepts of his Heart failure study are interwoven with issues in Heart disease, Pathophysiology and Sudden cardiac death.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Third universal definition of myocardial infarction
Kristian Thygesen;Joseph S. Alpert;Allan S. Jaffe;Maarten L. Simoons.
Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.
Elliott Antman;Jean-Pierre Bassand;Werner Klein;Magnus Ohman.
Journal of the American College of Cardiology (2000)
An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.
Maarten Simoons;Eric Topol;Robert Califf;Frans van de Werf.
The New England Journal of Medicine (1993)
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology.
Gilles Montalescot;Udo Sechtem;Stephan Achenbach;Felicita Andreotti.
European Heart Journal (2013)
Universal definition of myocardial infarction.
Kristian Thygesen;Joseph S. Alpert;Harvey D. White;Allan S. Jaffe.
European Heart Journal (2007)
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.
Guy De Backer;Ettore Ambrosioni;Knut Borch-Johnsen;Carlos Brotons.
European Heart Journal (2003)
Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour.
Eric Boersma;Arthur Cp Maas;Jaap W Deckers;Maarten L Simoons.
The Lancet (1996)
Guidelines on the management of stable angina pectoris: executive summary
Kim Fox;Maria Angeles Alonso Garcia;Diego Ardissino;Pawel Buszman.
European Heart Journal (2006)
Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
Micheal E. Bertrand;Maarten L. Simoons;Keith A.A. Fox;Lars C. Wallentin.
European Heart Journal (2002)
Dabigatran versus Warfarin in Patients with Mechanical Heart Valves
John W. Eikelboom;Stuart J. Connolly;Martina Brueckmann;Christopher B. Granger.
The New England Journal of Medicine (2013)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: